Author
Listed:
- Atilla Rexhepi
(University of Tetovo, RN Macedonia)
- Valon Asani
(Clinical Hospital Tetovo, RN Macedonia)
- Hysni Ismaili
(University of Tetovo, RN Macedonia)
- Fisnik Demiri
(Clinical Hospital Tetovo, RN Macedonia)
- Vlora Ibrahimi
(Clinical Hospital Tetovo, RN Macedonia)
- Ylber Jani
(Heart Diagnostica- Debar, RN Macedonia)
Abstract
Objectives: Atrial fibrillation (AF) is one of the main cardiovascular complications associated with type 2 diabetes mellitus (T2DM). Echocardiography-derived total atrial activation time (PA-TDI duration) which reflects electrical and structural changes to the atria, consistently and accurately predicts new-onset AF. In this study, we aimed to determine the value of PA-TDI duration in T2DM patients. Methods: A total of 40 consecutive patients with T2DM, mean age 51.5 ± 14.3 years, and 40 age and gender-matched healthy volunteers were evaluated. Conventional and tissue Doppler echocardiography were performed. Additionally, we determined the PA-TDI duration as the time interval from the onset of the P-wave in lead II of the ECG to the peak A’-wave on the tissue Doppler tracing. Results: Left atrial (LA) diameter and LA volume index were significantly higher in T2DM patients (3.36 ± 0.5 cm vs.3.10 ± 0.45cm, p=0.037; 30.8 ± 30ml/m2 vs. 29.0 ± 3.4ml/m2, p=0.03 respectively). Mitral A velocity was significantly higher in T2DM patients (69.72 ± 10.16 cm/s vs. 64.75 ± 10.64 cm/s, p=0.029). Doppler E/A ratio was lower in T2DM patients. Tissue Doppler E’/A’ ratio for left ventricular lateral annulus was significantly lower in the diabetic group (1.28±0.33 vs. 1.49±0.40, p=0.024) and E/E’ was significantly higher in the diabetic group (7.33±2.5 vs. 6.45±1.1, p=0.038). PA-TDI duration was significantly higher in the T2DM patients when compared with the controls (134.2±6.0ms vs. 124.3±9.4ms p
Suggested Citation
Atilla Rexhepi & Valon Asani & Hysni Ismaili & Fisnik Demiri & Vlora Ibrahimi & Ylber Jani, 2022.
"Assessment of Echocardiography-Derived Total Atrial Activation Time at Patients with Type 2 Diabetes Mellitus,"
European Journal of Medical and Health Sciences, European Open Science, vol. 4(3), pages 23-26, May.
Handle:
RePEc:epw:ejmed0:v:4:y:2022:i:3:id:41319
DOI: 10.24018/ejmed.2022.4.3.1319
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:4:y:2022:i:3:id:41319. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.